Bulletin
Investor Alert

London Markets Open in:

Corbus Pharmaceuticals Holdings Inc.

NAS: CRBP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 29, 2020, 7:12 p.m.

/zigman2/quotes/201549545/composite

$

7.48

Change

+0.02 +0.27%

Volume

Volume 108,066

Quotes are delayed by 20 min

/zigman2/quotes/201549545/composite

Previous close

$ 7.48

$ 7.46

Change

-0.02 -0.27%

Day low

Day high

$7.06

$7.69

Open

52 week low

52 week high

$3.29

$8.66

Open

Insider Actions for Corbus Pharmaceuticals Holdings Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/17/2020 Barbara White
Chief Medical Officer
15,606   Acquisition at $3.63 per share. 56,649
03/17/2020 Yuval Cohen
Chief Executive Officer; Director
4,300   Acquisition at $3.49 per share. 15,007
03/17/2020 Robert Discordia
Chief Operating Officer
2,840   Acquisition at $3.54 per share. 10,053
03/17/2020 Craig Millian
Chief Commercial Officer
2,000   Acquisition at $4.25 per share. 8,500
11/12/2019 Barbara White
Chief Medical Officer
3,424   Acquisition at $4.38 per share. 14,997
11/12/2019 Yuval Cohen
Chief Executive Officer; Director
1,430   Acquisition at $4.26 per share. 6,091
11/11/2019 Robert Discordia
Chief Operating Officer
2,500   Acquisition at $4.62 per share. 11,550
11/11/2019 Craig Millian
Chief Commercial Officer
1,000   Acquisition at $4.38 per share. 4,380
08/15/2019 Craig Millian
Chief Commercial Officer
1,500   Acquisition at $5.48 per share. 8,220
08/12/2019 Barbara White
Chief Medical Officer
1,639   Acquisition at $6.1 per share. 9,997
08/12/2019 Yuval Cohen
Chief Executive Officer; Director
1,175   Acquisition at $6.06 per share. 7,120
08/12/2019 Robert Discordia
Chief Operating Officer
15,000   Acquisition at $5.86 per share. 87,900
08/12/2019 Craig Millian
Chief Commercial Officer
1,500   Acquisition at $6 per share. 9,000
05/17/2019 Barbara White
Chief Medical Officer
1,389   Acquisition at $7.2 per share. 10,000
05/14/2019 Sean F. Moran
Chief Financial Officer
100   Acquisition at $7.12 per share. 712
05/14/2019 Craig Millian
Chief Commercial Officer
1,000   Acquisition at $7.23 per share. 7,230
05/13/2019 Yuval Cohen
Chief Executive Officer; Director
995   Acquisition at $6.99 per share. 6,955
03/15/2019 David P. Hochman
Director
2,000   Acquisition at $6.98 per share. 13,960
03/15/2019 John Kenneth Jenkins
Director
1,000   Acquisition at $6.98 per share. 6,980
03/14/2019 Sean F. Moran
Chief Financial Officer
1,500   Acquisition at $6.67 per share. 10,005
03/14/2019 Barbara White
Chief Medical Officer
4,638   Acquisition at $6.47 per share. 30,007
03/14/2019 Yuval Cohen
Chief Executive Officer; Director
1,530   Acquisition at $6.49 per share. 9,929
03/14/2019 Craig Millian
Chief Commercial Officer
5,000   Acquisition at $6.85 per share. 34,250

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
4 Purchases
0 Sales
24,746
0
Last 6 months
4 Purchases
0 Sales
24,746
0
Last 12 months
13 Purchases
0 Sales
53,914
0

Officers and Executives

Dr. Yuval Cohen
Chief Executive Officer & Director
Dr. Robert Discordia
Chief Operating Officer
Mr. Sean F. Moran
Chief Financial & Accounting Officer
Dr. Barbara White
Chief Medical Officer
Dr. Sergei Atamas
Executive Director-Research
Mr. Craig Millian
Chief Commercial Officer
Mr. David P. Hochman
Director
Mr. Ross Lobell
Vice President-Regulatory Affairs
Mr. Alan F. Holmer
Chairman
Dr. Peter Salzmann
Independent Director
Mr. Avery W. Catlin
Independent Director
Ms. Rachelle Jacques
Independent Director
Dr. John Kenneth Jenkins
Independent Director
Link to MarketWatch's Slice.